Codexis Stock Performance
| CDXS Stock | USD 1.64 0.04 2.38% |
The firm shows a Beta (market volatility) of 2.3, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Codexis will likely underperform. At this point, Codexis has a negative expected return of -0.57%. Please make sure to confirm Codexis' treynor ratio, as well as the relationship between the accumulation distribution and price action indicator , to decide if Codexis performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Codexis has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2026. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
| Begin Period Cash Flow | 66.7 M | |
| Total Cashflows From Investing Activities | -57 M |
Codexis Relative Risk vs. Return Landscape
If you would invest 250.00 in Codexis on October 12, 2025 and sell it today you would lose (86.00) from holding Codexis or give up 34.4% of portfolio value over 90 days. Codexis is currently does not generate positive expected returns and assumes 4.5504% risk (volatility on return distribution) over the 90 days horizon. In different words, 40% of stocks are less volatile than Codexis, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Codexis Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Codexis' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Codexis, and traders can use it to determine the average amount a Codexis' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1255
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CDXS |
Based on monthly moving average Codexis is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Codexis by adding Codexis to a well-diversified portfolio.
Codexis Fundamentals Growth
Codexis Stock prices reflect investors' perceptions of the future prospects and financial health of Codexis, and Codexis fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Codexis Stock performance.
| Return On Equity | -1.14 | ||||
| Return On Asset | -0.27 | ||||
| Profit Margin | (1.21) % | ||||
| Operating Margin | (2.20) % | ||||
| Current Valuation | 161.66 M | ||||
| Shares Outstanding | 90.32 M | ||||
| Price To Earning | (16.02) X | ||||
| Price To Book | 3.94 X | ||||
| Price To Sales | 2.80 X | ||||
| Revenue | 59.34 M | ||||
| EBITDA | (58.52 M) | ||||
| Cash And Equivalents | 90.11 M | ||||
| Cash Per Share | 1.38 X | ||||
| Total Debt | 59.9 M | ||||
| Debt To Equity | 0.29 % | ||||
| Book Value Per Share | 0.43 X | ||||
| Cash Flow From Operations | (49.41 M) | ||||
| Earnings Per Share | (0.73) X | ||||
| Total Asset | 149.01 M | ||||
| Retained Earnings | (562.81 M) | ||||
| Current Asset | 32.84 M | ||||
| Current Liabilities | 14.84 M | ||||
About Codexis Performance
Assessing Codexis' fundamental ratios provides investors with valuable insights into Codexis' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Codexis is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company was incorporated in 2002 and is headquartered in Redwood City, California. Codexis operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 261 people.Things to note about Codexis performance evaluation
Checking the ongoing alerts about Codexis for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Codexis help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Codexis generated a negative expected return over the last 90 days | |
| Codexis may become a speculative penny stock | |
| Codexis has high historical volatility and very poor performance | |
| Codexis has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 59.34 M. Net Loss for the year was (65.28 M) with loss before overhead, payroll, taxes, and interest of (10.7 M). | |
| Codexis currently holds about 90.11 M in cash with (49.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.38. | |
| Codexis has a frail financial position based on the latest SEC disclosures | |
| Roughly 70.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Codexis' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Codexis' stock is overvalued or undervalued compared to its peers.
- Examining Codexis' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Codexis' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Codexis' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Codexis' stock. These opinions can provide insight into Codexis' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Codexis Stock Analysis
When running Codexis' price analysis, check to measure Codexis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Codexis is operating at the current time. Most of Codexis' value examination focuses on studying past and present price action to predict the probability of Codexis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Codexis' price. Additionally, you may evaluate how the addition of Codexis to your portfolios can decrease your overall portfolio volatility.